Global Dermatological Therapeutics Market Growth 2022-2028

February 2022 | 105 pages | ID: G13EC50EF6FBEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Dermatological Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Dermatological Therapeutics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Dermatological Therapeutics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Dermatological Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dermatological Therapeutics market, reaching US$ million by the year 2028. As for the Europe Dermatological Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Dermatological Therapeutics players cover AGI Dermatics, Allergan, Amgen, and Chester Valley, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Dermatological Therapeutics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

• Anti-infectives
• Corticosteroids
• Anti Psoriasis
• Anti-acne
• Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

• Hospital
• Clinic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

• AGI Dermatics
• Allergan
• Amgen
• Chester Valley
• Dermik
• Eisai
• Ferndale
• Genentech
• Medicis
• Onset Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dermatological Therapeutics Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Dermatological Therapeutics by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Dermatological Therapeutics by Country/Region, 2017, 2022 & 2028
2.2 Dermatological Therapeutics Segment by Type
  2.2.1 Anti-infectives
  2.2.2 Corticosteroids
  2.2.3 Anti Psoriasis
  2.2.4 Anti-acne
  2.2.5 Others
2.3 Dermatological Therapeutics Sales by Type
  2.3.1 Global Dermatological Therapeutics Sales Market Share by Type (2017-2022)
  2.3.2 Global Dermatological Therapeutics Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Dermatological Therapeutics Sale Price by Type (2017-2022)
2.4 Dermatological Therapeutics Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
2.5 Dermatological Therapeutics Sales by Application
  2.5.1 Global Dermatological Therapeutics Sale Market Share by Application (2017-2022)
  2.5.2 Global Dermatological Therapeutics Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Dermatological Therapeutics Sale Price by Application (2017-2022)

3 GLOBAL DERMATOLOGICAL THERAPEUTICS BY COMPANY

3.1 Global Dermatological Therapeutics Breakdown Data by Company
  3.1.1 Global Dermatological Therapeutics Annual Sales by Company (2020-2022)
  3.1.2 Global Dermatological Therapeutics Sales Market Share by Company (2020-2022)
3.2 Global Dermatological Therapeutics Annual Revenue by Company (2020-2022)
  3.2.1 Global Dermatological Therapeutics Revenue by Company (2020-2022)
  3.2.2 Global Dermatological Therapeutics Revenue Market Share by Company (2020-2022)
3.3 Global Dermatological Therapeutics Sale Price by Company
3.4 Key Manufacturers Dermatological Therapeutics Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Dermatological Therapeutics Product Location Distribution
  3.4.2 Players Dermatological Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR DERMATOLOGICAL THERAPEUTICS BY GEOGRAPHIC REGION

4.1 World Historic Dermatological Therapeutics Market Size by Geographic Region (2017-2022)
  4.1.1 Global Dermatological Therapeutics Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Dermatological Therapeutics Annual Revenue by Geographic Region
4.2 World Historic Dermatological Therapeutics Market Size by Country/Region (2017-2022)
  4.2.1 Global Dermatological Therapeutics Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Dermatological Therapeutics Annual Revenue by Country/Region
4.3 Americas Dermatological Therapeutics Sales Growth
4.4 APAC Dermatological Therapeutics Sales Growth
4.5 Europe Dermatological Therapeutics Sales Growth
4.6 Middle East & Africa Dermatological Therapeutics Sales Growth

5 AMERICAS

5.1 Americas Dermatological Therapeutics Sales by Country
  5.1.1 Americas Dermatological Therapeutics Sales by Country (2017-2022)
  5.1.2 Americas Dermatological Therapeutics Revenue by Country (2017-2022)
5.2 Americas Dermatological Therapeutics Sales by Type
5.3 Americas Dermatological Therapeutics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dermatological Therapeutics Sales by Region
  6.1.1 APAC Dermatological Therapeutics Sales by Region (2017-2022)
  6.1.2 APAC Dermatological Therapeutics Revenue by Region (2017-2022)
6.2 APAC Dermatological Therapeutics Sales by Type
6.3 APAC Dermatological Therapeutics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Dermatological Therapeutics by Country
  7.1.1 Europe Dermatological Therapeutics Sales by Country (2017-2022)
  7.1.2 Europe Dermatological Therapeutics Revenue by Country (2017-2022)
7.2 Europe Dermatological Therapeutics Sales by Type
7.3 Europe Dermatological Therapeutics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dermatological Therapeutics by Country
  8.1.1 Middle East & Africa Dermatological Therapeutics Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Dermatological Therapeutics Revenue by Country (2017-2022)
8.2 Middle East & Africa Dermatological Therapeutics Sales by Type
8.3 Middle East & Africa Dermatological Therapeutics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dermatological Therapeutics
10.3 Manufacturing Process Analysis of Dermatological Therapeutics
10.4 Industry Chain Structure of Dermatological Therapeutics

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Dermatological Therapeutics Distributors
11.3 Dermatological Therapeutics Customer

12 WORLD FORECAST REVIEW FOR DERMATOLOGICAL THERAPEUTICS BY GEOGRAPHIC REGION

12.1 Global Dermatological Therapeutics Market Size Forecast by Region
  12.1.1 Global Dermatological Therapeutics Forecast by Region (2023-2028)
  12.1.2 Global Dermatological Therapeutics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dermatological Therapeutics Forecast by Type
12.7 Global Dermatological Therapeutics Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 AGI Dermatics
  13.1.1 AGI Dermatics Company Information
  13.1.2 AGI Dermatics Dermatological Therapeutics Product Offered
  13.1.3 AGI Dermatics Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 AGI Dermatics Main Business Overview
  13.1.5 AGI Dermatics Latest Developments
13.2 Allergan
  13.2.1 Allergan Company Information
  13.2.2 Allergan Dermatological Therapeutics Product Offered
  13.2.3 Allergan Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Allergan Main Business Overview
  13.2.5 Allergan Latest Developments
13.3 Amgen
  13.3.1 Amgen Company Information
  13.3.2 Amgen Dermatological Therapeutics Product Offered
  13.3.3 Amgen Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Amgen Main Business Overview
  13.3.5 Amgen Latest Developments
13.4 Chester Valley
  13.4.1 Chester Valley Company Information
  13.4.2 Chester Valley Dermatological Therapeutics Product Offered
  13.4.3 Chester Valley Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Chester Valley Main Business Overview
  13.4.5 Chester Valley Latest Developments
13.5 Dermik
  13.5.1 Dermik Company Information
  13.5.2 Dermik Dermatological Therapeutics Product Offered
  13.5.3 Dermik Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Dermik Main Business Overview
  13.5.5 Dermik Latest Developments
13.6 Eisai
  13.6.1 Eisai Company Information
  13.6.2 Eisai Dermatological Therapeutics Product Offered
  13.6.3 Eisai Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Eisai Main Business Overview
  13.6.5 Eisai Latest Developments
13.7 Ferndale
  13.7.1 Ferndale Company Information
  13.7.2 Ferndale Dermatological Therapeutics Product Offered
  13.7.3 Ferndale Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Ferndale Main Business Overview
  13.7.5 Ferndale Latest Developments
13.8 Genentech
  13.8.1 Genentech Company Information
  13.8.2 Genentech Dermatological Therapeutics Product Offered
  13.8.3 Genentech Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Genentech Main Business Overview
  13.8.5 Genentech Latest Developments
13.9 Medicis
  13.9.1 Medicis Company Information
  13.9.2 Medicis Dermatological Therapeutics Product Offered
  13.9.3 Medicis Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Medicis Main Business Overview
  13.9.5 Medicis Latest Developments
13.10 Onset Therapeutics
  13.10.1 Onset Therapeutics Company Information
  13.10.2 Onset Therapeutics Dermatological Therapeutics Product Offered
  13.10.3 Onset Therapeutics Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Onset Therapeutics Main Business Overview
  13.10.5 Onset Therapeutics Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Dermatological Therapeutics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Dermatological Therapeutics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Anti-infectives
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Anti Psoriasis
Table 6. Major Players of Anti-acne
Table 7. Major Players of Others
Table 8. Global Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 9. Global Dermatological Therapeutics Sales Market Share by Type (2017-2022)
Table 10. Global Dermatological Therapeutics Revenue by Type (2017-2022) & ($ million)
Table 11. Global Dermatological Therapeutics Revenue Market Share by Type (2017-2022)
Table 12. Global Dermatological Therapeutics Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 14. Global Dermatological Therapeutics Sales Market Share by Application (2017-2022)
Table 15. Global Dermatological Therapeutics Revenue by Application (2017-2022)
Table 16. Global Dermatological Therapeutics Revenue Market Share by Application (2017-2022)
Table 17. Global Dermatological Therapeutics Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Dermatological Therapeutics Sales by Company (2020-2022) & (K Units)
Table 19. Global Dermatological Therapeutics Sales Market Share by Company (2020-2022)
Table 20. Global Dermatological Therapeutics Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Dermatological Therapeutics Revenue Market Share by Company (2020-2022)
Table 22. Global Dermatological Therapeutics Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Dermatological Therapeutics Producing Area Distribution and Sales Area
Table 24. Players Dermatological Therapeutics Products Offered
Table 25. Dermatological Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Dermatological Therapeutics Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Dermatological Therapeutics Sales Market Share Geographic Region (2017-2022)
Table 30. Global Dermatological Therapeutics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Dermatological Therapeutics Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Dermatological Therapeutics Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Dermatological Therapeutics Sales Market Share by Country/Region (2017-2022)
Table 34. Global Dermatological Therapeutics Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Dermatological Therapeutics Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Dermatological Therapeutics Sales by Country (2017-2022) & (K Units)
Table 37. Americas Dermatological Therapeutics Sales Market Share by Country (2017-2022)
Table 38. Americas Dermatological Therapeutics Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Dermatological Therapeutics Revenue Market Share by Country (2017-2022)
Table 40. Americas Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 41. Americas Dermatological Therapeutics Sales Market Share by Type (2017-2022)
Table 42. Americas Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 43. Americas Dermatological Therapeutics Sales Market Share by Application (2017-2022)
Table 44. APAC Dermatological Therapeutics Sales by Region (2017-2022) & (K Units)
Table 45. APAC Dermatological Therapeutics Sales Market Share by Region (2017-2022)
Table 46. APAC Dermatological Therapeutics Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Dermatological Therapeutics Revenue Market Share by Region (2017-2022)
Table 48. APAC Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 49. APAC Dermatological Therapeutics Sales Market Share by Type (2017-2022)
Table 50. APAC Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 51. APAC Dermatological Therapeutics Sales Market Share by Application (2017-2022)
Table 52. Europe Dermatological Therapeutics Sales by Country (2017-2022) & (K Units)
Table 53. Europe Dermatological Therapeutics Sales Market Share by Country (2017-2022)
Table 54. Europe Dermatological Therapeutics Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Dermatological Therapeutics Revenue Market Share by Country (2017-2022)
Table 56. Europe Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 57. Europe Dermatological Therapeutics Sales Market Share by Type (2017-2022)
Table 58. Europe Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 59. Europe Dermatological Therapeutics Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Dermatological Therapeutics Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Dermatological Therapeutics Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Dermatological Therapeutics Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Dermatological Therapeutics Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Dermatological Therapeutics Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Dermatological Therapeutics Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Dermatological Therapeutics
Table 69. Key Market Challenges & Risks of Dermatological Therapeutics
Table 70. Key Industry Trends of Dermatological Therapeutics
Table 71. Dermatological Therapeutics Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Dermatological Therapeutics Distributors List
Table 74. Dermatological Therapeutics Customer List
Table 75. Global Dermatological Therapeutics Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Dermatological Therapeutics Sales Market Forecast by Region
Table 77. Global Dermatological Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Dermatological Therapeutics Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Dermatological Therapeutics Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Dermatological Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Dermatological Therapeutics Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Dermatological Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Dermatological Therapeutics Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Dermatological Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Dermatological Therapeutics Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Dermatological Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Dermatological Therapeutics Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Dermatological Therapeutics Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Dermatological Therapeutics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Dermatological Therapeutics Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Dermatological Therapeutics Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Dermatological Therapeutics Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Dermatological Therapeutics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Dermatological Therapeutics Revenue Market Share Forecast by Application (2023-2028)
Table 95. AGI Dermatics Basic Information, Dermatological Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 96. AGI Dermatics Dermatological Therapeutics Product Offered
Table 97. AGI Dermatics Dermatological Therapeutics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. AGI Dermatics Main Business
Table 99. AGI Dermatics Latest Developments
Table 100. Allergan Basic Information, Dermatological Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 101. Allergan Dermatological Therapeutics Product Offered
Table 102. Allergan Dermatological Therapeutics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Allergan Main Business
Table 104. Allergan Latest Developments
Table 105. Amgen Basic Information, Dermatological Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 106. Amgen Dermatological Therapeutics Product Offered
Table 107. Amgen Dermatological Therapeutics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Amgen Main Business
Table 109. Amgen Latest Developments
Table 110. Chester Valley Basic Information, Dermatological Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 111. Chester Valley Dermatological Therapeutics Product Offered
Table 112. Chester Valley Dermatological Therapeutics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Chester Valley Main Business
Table 114. Chester Valley Latest Developments
Table 115. Dermik Basic Information, Dermatological Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 116. Dermik Dermatological Therapeutics Product Offered
Table 117. Dermik Dermatological Therapeutics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Dermik Main Business
Table 119. Dermik Latest Developments
Table 120. Eisai Basic Information, Dermatological Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 121. Eisai Dermatological Therapeutics Product Offered
Table 122. Eisai Dermatological Therapeutics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Eisai Main Business
Table 124. Eisai Latest Developments
Table 125. Ferndale Basic Information, Dermatological Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 126. Ferndale Dermatological Therapeutics Product Offered
Table 127. Ferndale Dermatological Therapeutics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Ferndale Main Business
Table 129. Ferndale Latest Developments
Table 130. Genentech Basic Information, Dermatological Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 131. Genentech Dermatological Therapeutics Product Offered
Table 132. Genentech Dermatological Therapeutics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Genentech Main Business
Table 134. Genentech Latest Developments
Table 135. Medicis Basic Information, Dermatological Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 136. Medicis Dermatological Therapeutics Product Offered
Table 137. Medicis Dermatological Therapeutics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Medicis Main Business
Table 139. Medicis Latest Developments
Table 140. Onset Therapeutics Basic Information, Dermatological Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 141. Onset Therapeutics Dermatological Therapeutics Product Offered
Table 142. Onset Therapeutics Dermatological Therapeutics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Onset Therapeutics Main Business
Table 144. Onset Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Dermatological Therapeutics
Figure 2. Dermatological Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dermatological Therapeutics Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Dermatological Therapeutics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Dermatological Therapeutics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Anti-infectives
Figure 10. Product Picture of Corticosteroids
Figure 11. Product Picture of Anti Psoriasis
Figure 12. Product Picture of Anti-acne
Figure 13. Product Picture of Others
Figure 14. Global Dermatological Therapeutics Sales Market Share by Type in 2021
Figure 15. Global Dermatological Therapeutics Revenue Market Share by Type (2017-2022)
Figure 16. Dermatological Therapeutics Consumed in Hospital
Figure 17. Global Dermatological Therapeutics Market: Hospital (2017-2022) & (K Units)
Figure 18. Dermatological Therapeutics Consumed in Clinic
Figure 19. Global Dermatological Therapeutics Market: Clinic (2017-2022) & (K Units)
Figure 20. Global Dermatological Therapeutics Sales Market Share by Application (2017-2022)
Figure 21. Global Dermatological Therapeutics Revenue Market Share by Application in 2021
Figure 22. Dermatological Therapeutics Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Dermatological Therapeutics Revenue Market Share by Company in 2021
Figure 24. Global Dermatological Therapeutics Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Dermatological Therapeutics Revenue Market Share by Geographic Region in 2021
Figure 26. Global Dermatological Therapeutics Sales Market Share by Region (2017-2022)
Figure 27. Global Dermatological Therapeutics Revenue Market Share by Country/Region in 2021
Figure 28. Americas Dermatological Therapeutics Sales 2017-2022 (K Units)
Figure 29. Americas Dermatological Therapeutics Revenue 2017-2022 ($ Millions)
Figure 30. APAC Dermatological Therapeutics Sales 2017-2022 (K Units)
Figure 31. APAC Dermatological Therapeutics Revenue 2017-2022 ($ Millions)
Figure 32. Europe Dermatological Therapeutics Sales 2017-2022 (K Units)
Figure 33. Europe Dermatological Therapeutics Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Dermatological Therapeutics Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Dermatological Therapeutics Revenue 2017-2022 ($ Millions)
Figure 36. Americas Dermatological Therapeutics Sales Market Share by Country in 2021
Figure 37. Americas Dermatological Therapeutics Revenue Market Share by Country in 2021
Figure 38. United States Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Dermatological Therapeutics Sales Market Share by Region in 2021
Figure 43. APAC Dermatological Therapeutics Revenue Market Share by Regions in 2021
Figure 44. China Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Dermatological Therapeutics Sales Market Share by Country in 2021
Figure 51. Europe Dermatological Therapeutics Revenue Market Share by Country in 2021
Figure 52. Germany Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Dermatological Therapeutics Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Dermatological Therapeutics Revenue Market Share by Country in 2021
Figure 59. Egypt Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Dermatological Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Dermatological Therapeutics in 2021
Figure 65. Manufacturing Process Analysis of Dermatological Therapeutics
Figure 66. Industry Chain Structure of Dermatological Therapeutics
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles